Jay M Moyes insider trades: Puma Biotechnology (PBYI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jay reports to the SEC
and 3 more companies
Open-market buys and sales
27 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | PBYI | ↓ Sell | 22,000 | $7.22 | $159K | Direct | Jun 15, 2026 (3d) |
| Feb 23, 2026 | SINT | ↑ Buy | 1,000 | $2.91 | $3K | Direct | Feb 25, 2026 (2d) |
| Aug 26, 2025 | SINT | ↑ Buy | 3,000 | $3.59 | $11K | Direct | Aug 27, 2025 (1d) |
| Jun 13, 2025 | PBYI | ↓ Sell | 22,000 | $3.40 | $75K | Direct | Jun 17, 2025 (4d) |
| Jun 13, 2024 | PBYI | ↓ Sell | 22,000 | $3.34 | $73K | Direct | Jun 17, 2024 (4d) |
| Jun 13, 2023 | PBYI | ↓ Sell | 22,000 | $3.45 | $76K | Direct | Jun 15, 2023 (2d) |
| Jun 16, 2022 | PBYI | ↓ Sell10b5-1 | 22,858 | $2.64 | $60K | Direct | Jun 21, 2022 (5d) |
| Jun 10, 2021 | PBYI | ↓ Sell | 25,248 | $11.36 | $287K | Direct | Jun 11, 2021 (1d) |
| Sep 16, 2020 | PBYI | ↓ Sell | 9,703 | $10.00 | $97K | Direct | Sep 17, 2020 (1d) |
| Jun 16, 2020 | PBYI | ↓ Sell | 9,720 | $9.50 | $92K | Direct | Jun 17, 2020 (1d) |
| Oct 15, 2007 | MYGN | ↓ Sell | 10,036 | $55.11 | $553K | Direct | Oct 16, 2007 (1d) |
| Oct 15, 2007 | MYGN | ↓ Sell | 9,866 | $55.05 | $543K | Direct | Oct 16, 2007 (1d) |
| Oct 15, 2007 | MYGN | ↓ Sell | 9,010 | $54.75 | $493K | Direct | Oct 16, 2007 (1d) |
| Oct 15, 2007 | MYGN | ↓ Sell | 5,931 | $55.20 | $327K | Direct | Oct 16, 2007 (1d) |
| Oct 15, 2007 | MYGN | ↓ Sell | 4,677 | $55.50 | $260K | Direct | Oct 16, 2007 (1d) |
| Sep 13, 2007 | MYGN | ↓ Sell | 28,196 | $47.21 | $1.3M | Direct | Sep 14, 2007 (1d) |
| Sep 13, 2007 | MYGN | ↓ Sell | 24,897 | $47.24 | $1.2M | Direct | Sep 14, 2007 (1d) |
| Sep 13, 2007 | MYGN | ↓ Sell | 14,481 | $47.29 | $685K | Direct | Sep 14, 2007 (1d) |
| Sep 13, 2007 | MYGN | ↓ Sell | 12,233 | $47.33 | $579K | Direct | Sep 14, 2007 (1d) |
| Sep 13, 2007 | MYGN | ↓ Sell | 471 | $47.22 | $22K | Direct | Sep 14, 2007 (1d) |
| Jun 15, 2007 | MYGN | ↓ Sell | 1,500 | $37.73 | $57K | Direct | Jun 18, 2007 (3d) |
| Jan 9, 2007 | MYGN | ↓ Sell | 8,156 | $32.50 | $265K | Direct | Jan 11, 2007 (2d) |
| Nov 20, 2006 | MYGN | ↓ Sell | 8,156 | $30.00 | $245K | Direct | Nov 20, 2006 (0d) |
| Oct 18, 2006 | MYGN | ↓ Sell | 5,000 | $27.08 | $135K | Direct | Oct 18, 2006 (0d) |
| Feb 27, 2006 | MYGN | ↓ Sell | 2,900 | $25.21 | $73K | Direct | Feb 27, 2006 (0d) |
| Feb 10, 2006 | MYGN | ↓ Sell | 12,544 | $25.03 | $314K | Direct | Feb 14, 2006 (4d) |
| Dec 21, 2005 | MYGN | ↓ Sell | 2,448 | $19.98 | $49K | Direct | Dec 21, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PBYI insiders
Open-market trades in the last 12 months
About Jay M Moyes's insider trades
Jay M Moyes is a director at Puma Biotechnology (PBYI). Since Dec 21, 2005, Jay has reported 2 open-market purchases worth $14K and 25 sales worth $8.0M on SEC Form 4. In the last 12 months: 1 buy ($3K) and 1 sale ($159K).
1 sale (1% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (52 filings), option exercises (22 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PBYI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.